2.40Open2.40Pre Close0 Volume41 Open Interest22.50Strike Price0.00Turnover62.15%IV1.10%PremiumAug 16, 2024Expiry Date2.13Intrinsic Value100Multiplier22DDays to Expiry0.27Extrinsic Value100Contract SizeAmericanOptions Type0.7538Delta0.0833Gamma8.80Leverage Ratio-0.0292Theta0.0096Rho6.63Eff Leverage0.0192Vega
Syndax Pharmaceuticals Stock Discussion
MT Newswires· 1 min ago
Syndax Pharmaceuticals (SNDX) said late Tuesday the US Food and Drug Administration has granted priority review for the company's new drug application for revumenib to treat relapsed or refractory acute leukemia, a type of cancer.
The company said the filing was assigned a prescription drug user fee act target action date of S...
3 MINUTES AGO, 7:00 AM EDT
VIA PR NEWSWIRE
$Syndax Pharmaceuticals(SNDX.US)$ experienced a 7.10% decline in its stock price during the previous trading session, accompanied by high options activity. The company's option volume reached 36.97K with an IV percentile of 100% and implied volatility ...
$Syndax Pharmaceuticals(SNDX.US)$ experienced a 3.30% increase in stock price during the previous trading session, accompanied by high options activity. The company's option volume peaked at 49.82K with an IV percentile of 94% and a current implied vol...
No comment yet